EC Approved Pfizer’s HYMPAVZI™ (marstacimab) for Treatment of Adults and Adolescents with Severe Hemophilia
On Nov, 20, 2024, Pfizer announced that the European Commission (EC) has granted marketing authorization for HYMPAVZI™ (marstacimab)…
Human Cell Atlas achieved leap in understanding of the human body
On Nov. 20, 2024, researchers with the global Human Cell Atlas (HCA) consortium reported significant progress in their…
Texas A&M Researchers Uncovered Secrets Of Horse Genetics For Conservation, Breeding
On Nov. 20, 2024, a research collaboration between the Texas A&M College of Veterinary Medicine and Biomedical Sciences…
AARP and Leading Research Organizations Announced Risk Factors of Dementia Research Findings
On Nov. 15, 2024, the AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for…
Biotechnology | Diagnostics | Disease | Polio | Vaccine | Women's Health
U.S. Earned D+ Grade for Preterm Birth Rate in 2024 March of Dimes Report Card, Worst Grade in Report History
On Nov. 14, 2024, the March of Dimes released its 2024 Report Card, revealing the U.S. preterm birth…
nearly 260 million people in the U.S. predicted to have overweight or obesity by 2050
On Nov. 14, 2024, an analysis from the Global Burden of Disease Study Collaborator Network warned of an…
Urgent action needed as global diabetes cases increase four-fold over past decades
On Nov. 13, 2024, the NCD Risk Factor Collaboration (NCD-RisC) with support from the World Health Organization (WHO)…
Biotechnology | Diagnostics | Disease | Neurology | Oncology | Therapeutics
new Glioblastoma treatment attacks brain tumors from multiple angles
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences and Cleveland Clinic Presented Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
Alzheimer’s and alcohol use disorder share similar gene expression patterns
On Nov. 5, 2024, Scripps research scientists reported they have shown that Alzheimer’s and alcohol use disorder (AUD)…
Biotechnology | Diagnostics | Disease | Genomics | WHO
Landmark agreement adopted for nation’s sharing of genetic data
On Nov. 3, 2024, the world’s largest biodiversity summit, known as COP16, concluded with several landmark decisions, including…
Restricting sugar before birth and in early childhood greatly reduces risk of chronic disease later in life
On Nov. 1, 2024, researchers reported results from a study that show a low-sugar diet during pregnancy and…
Drug Supply Chain Issues More Likely to Result in Shortages in U.S. Than Canada
On Oct. 31, 2024, researchers from the University of Pittsburgh reported results of a study that showed drug-related…
Biotechnology | Chemical | Diagnostics | Disease | Environmental | Nanotechnology | Pharmaceutical | Therapeutics
Nanoplastics can reduce the effectiveness of antibiotics
On Oct. 30, 2024, an international research team led by the University of Bonn reported results of a…
Johns Hopkins and Family of Henrietta Lacks Break Ground on Building Named in Honor of Henrietta Lacks
On Oct. 28, 2024, the Johns Hopkins University and Johns Hopkins Medicine, together with descendants of Henrietta Lacks,…
Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older
On Oct. 23, 2024, Pfizer announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee…
Biotechnology | Dentistry | Diagnostics | Disease | Medicine | Orthopedic | Therapeutics
Rochester-based Saunders Foundation makes $30 million commitment to the University of Rochester Medical Center
On Oct. 23, 2024, the University of Rochester announced that the Saunders Foundation, led by University Trustee Emeritus…
Large-scale study of brain volume found genetic links to Parkinson’s disease and ADHD
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
Hospital price increases since 2000 outpaced inflation by more than double, Baker Institute reported
On Oct. 21, 2024, Rice University’s Baker Institute for Public Policy reported that hospital service prices surged more…
“Prevalence of glaucoma in the U.S. in 2022” study found higher prevalence of the eye disease than previously estimated
On Oct. 18, 2024, a study published in JAMA Ophthalmology, found that approximately 4.22 million people in the…
PET Scan based on lizard saliva detected rare tumor
On Oct. 18, 2024, a research team led by Radboud university medical center reported that a new PET…
Human skin map gives ‘recipe’ to build skin and could help prevent scarring
On Oct. 16, 2024, researchers from the Wellcome Sanger Institute, Newcastle University and their collaborators announced they had…
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
On Oct. 16, 2024, Sanofi announced it will contribute $18 million to three Historically Black Medical Schools to…
Lundbeck to acquire Longboard Pharmaceuticals for $2.6 billion
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
U.S. FDA Approved Pfizer’s HYMPAVZI™ (marstacimab-hncq) for Treatment of Adults and Adolescents with Hemophilia A or B
On Oct. 11, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved HYMPAVZI™ (marstacimab-hncq)…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…
Scientists develop a new method to study gene function in cells and tissue
On Oct. 7, 2024, Columbia University researchers announced they had developed a new optical pooled screening approach called…
Biotechnology | Diagnostics | Disease | FDA
FDA Approved Cologuard Plus Test, Setting New Benchmark in Colorectal Cancer Screening
On Oct. 4, 2024, Exact Sciences announced the U.S. Food and Drug Administration (FDA) had approved the Cologuard…
Biotechnology | Diagnostics | Disease | Genomics | Non-Profit Research | Rare Disease | Therapeutics | Women's Health
First newborn babies tested for over 200 genetic conditions as world-leading study begins in NHS hospitals
On Oct. 3, 2024, the National Health Service England (NHS) announced that Hundreds of babies have begun to…
Biotechnology | Chemical | Disease | Oncology
Combination Chemo Helps People with Leiomyosarcoma Live Longer
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…